
DSCSA is Delayed, Now What?
Explore the latest white paper, "DSCSA is Delayed, Now What?", uncovering pivotal insights into navigating the pharmaceutical landscape amidst regulatory shifts. Learn strategies and solutions to address challenges in data management, drug shortages and vendor relationships. Discover smarter purchasing strategies, including data consolidation and integrated technologies, ensuring seamless compliance with the Drug Supply Chain Security Act.
Despite the recent enforcement delay of the Drug Supply Chain Security Act (DSCSA) until November 27, 2024, this white paper serves as an invaluable guide for pharmacies navigating the intricacies of DSCSA compliance.
This white paper aims to delve into the challenges pharmacies will encounter, the critical need to act now and sustain compliance efforts and pragmatic strategies to propel pharmacies forward despite the regulatory delays.
The DSCSA is not merely a compliance checkbox. It’s a transformative
initiative that demands a seamless integration of technology, processes and staff training.
Complete the form below to learn more.
Sponsored By:
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.